QRG Capital Management’s AstraZeneca AZN Stock Holding History

QRG Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20M	Buy	105,760 +8,023	+8%	+$1.51M	0.17%	118
2026 Q1	$19.2M	Buy	97,737 +9,880	+11%	+$1.91M	0.2%	103
2025 Q4	$16.2M	Buy	87,857 +14,115	+19%	+$2.48M	0.18%	111
2025 Q3	$11.3M	Sell	73,742 -33,700	-31%	-$5.1M	0.14%	139
2025 Q2	$15M	Sell	107,442 -10,254	-9%	-$1.44M	0.13%	164
2025 Q1	$17.3M	Buy	117,696 +7,312	+7%	+$1.06M	0.18%	127
2024 Q4	$14.5M	Sell	110,384 -1,239	-1%	-$173K	0.15%	137
2024 Q3	$17.4M	Buy	111,623 +12,057	+12%	+$1.95M	0.19%	116
2024 Q2	$15.5M	Buy	99,566 +11,520	+13%	+$1.73M	0.18%	117
2024 Q1	$11.9M	Buy	88,046 +7,918	+10%	+$1.05M	0.15%	143
2023 Q4	$10.8M	Buy	80,128 +4,298	+6%	+$559K	0.16%	142
2023 Q3	$10.3M	Buy	+75,830	New	+$10.4M	0.18%	131

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

QRG Capital Management's AZN Position: Q2 2026 in Review

QRG Capital Management increased its AstraZeneca (AZN) stake by 8.2% in Q2 2026, buying an estimated $1.51M and bringing the position to 105,760 shares worth $20M. The position accounts for 0.17% of the portfolio, ranked #118.

QRG Capital Management first reported a position in AZN in Q3 2023 and has held it in 12 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

QRG Capital Management held 105,760 shares of AstraZeneca worth $20M as of Q2 2026.
QRG Capital Management bought 8,023 AstraZeneca shares in Q2 2026, an estimated $1.51M.
AstraZeneca made up 0.17% of QRG Capital Management's portfolio in Q2 2026, its #118 holding.
QRG Capital Management first reported a position in AstraZeneca in Q3 2023 and has held it in 12 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.